Insiders · ARMP

ARMP insider transactions

Armata Pharmaceuticals Inc. (ARMP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ARMP

• 40d
  SEC Form 4 filed by Director Gilmer Daniel B.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 40d
  SEC Form 3 filed by new insider Gilmer Daniel B.

  3 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 82d
  Chief Business Officer Kyme Pierre covered exercise/tax liability with 1,030 shares, decreasing direct ownership by 10% to 9,461 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 82d
  Chief Executive Officer Birx Deborah covered exercise/tax liability with 4,919 shares, decreasing direct ownership by 2% to 212,458 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 88d
  SEC Form 4 filed by Director Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 88d
  SEC Form 4 filed by Chief Business Officer Kyme Pierre

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 88d
  SEC Form 4 filed by SVP, Finance, and PFO House David Duane

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 88d
  SEC Form 4 filed by Director Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 88d
  SEC Form 4 filed by Director Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 88d
  SEC Form 4 filed by Director Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 88d
  SEC Form 4 filed by Chief Executive Officer Birx Deborah

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 88d
  SEC Form 4 filed by Director Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 88d
  SEC Form 4 filed by Director Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 328d
  Chief Executive Officer Birx Deborah covered exercise/tax liability with 13,637 shares, decreasing direct ownership by 6% to 217,377 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 408d
  Chief Executive Officer Birx Deborah covered exercise/tax liability with 28,986 shares, decreasing direct ownership by 11% to 231,014 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 408d
  Chief Business Officer Kyme Pierre covered exercise/tax liability with 1,027 shares, decreasing direct ownership by 9% to 10,491 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 408d
  Amendment: New insider Kyme Pierre claimed ownership of 1,518 shares (SEC Form 3)

  3/A - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 485d
  SEC Form 4 filed by Director Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 485d
  SEC Form 4 filed by Director Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 485d
  SEC Form 4 filed by Director Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 485d
  SEC Form 4 filed by Director Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 485d
  SEC Form 4 filed by Chief Business Officer Kyme Pierre

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 485d
  SEC Form 4 filed by Director Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 485d
  SEC Form 4 filed by SVP, Finance, and PFO House David Duane

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 485d
  SEC Form 4 filed by Director Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 485d
  SEC Form 4 filed by Chief Executive Officer Birx Deborah

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 612d
  SEC Form 4 filed by SVP, Finance, and PFO House David Duane

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 657d
  SEC Form 3 filed by new insider House David Duane

  3 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 709d
  New insider Kyme Pierre claimed ownership of 10,000 shares (SEC Form 3)

  3 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 811d
  SEC Form 4 filed by Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 811d
  SEC Form 4 filed by Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 811d
  SEC Form 4 filed by Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 811d
  Rychlik Richard was granted 10,000 shares (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 811d
  SEC Form 4 filed by Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 811d
  SEC Form 4 filed by Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 811d
  SEC Form 4 filed by Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 811d
  Birx Deborah was granted 60,000 shares, increasing direct ownership by 30% to 260,000 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 894d
  SEC Form 4 filed by Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 894d
  SEC Form 4 filed by Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 894d
  SEC Form 4 filed by Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 894d
  SEC Form 4 filed by Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 894d
  SEC Form 4 filed by Rychlik Richard

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 894d
  SEC Form 4 filed by Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 894d
  SEC Form 4 filed by Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 894d
  Birx Deborah was granted 200,000 shares (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 989d
  SEC Form 3 filed by new insider Rychlik Richard

  3 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1054d
  SEC Form 3 filed by new insider Birx Deborah

  3 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1126d
  SEC Form 3 filed by new insider Averill Julianne

  3 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1216d
  SEC Form 3 filed by new insider Butler Erin

  3 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1514d
  SEC Form 4 filed by Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1514d
  SEC Form 4 filed by Patrick Todd

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1514d
  SEC Form 4 filed by Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1514d
  SEC Form 4 filed by Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1514d
  SEC Form 4 filed by Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1514d
  SEC Form 4 filed by Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1514d
  SEC Form 4 filed by Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1514d
  SEC Form 4 filed by Morris Duane Alfred

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1514d
  SEC Form 4 filed by Varnum Brian

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1824d
  SEC Form 4 filed by Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1824d
  SEC Form 4 filed by PATTI JOSEPH M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)